Article
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.
Pharmacogenetics - 1 Aug 2004
Girard Hugo, Court Michael H, Bernard Olivier, Fortier Louis-Charles, Villeneuve Lyne, Hao Qin, Greenblatt David J, von Moltke Lisa L, Perussed Louis, Guillemette Chantal
Abstract excerpt
OBJECTIVES: Polymorphisms in UDP-glucuronosyltransferases (UGTs) can influence detoxifying capacities and have considerable therapeutic implications in addition to influence various (patho)physiological processes. UGT1A9 plays a central role in the metabolism of various classes of therapeutic drugs in addition to carcinogens and steroids. The great interindividual variability of UGT1A9-mediated glucuronidation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
